| The therapeutic potential of targeting ABC transporters to combat multi-drug resistance P Bugde, R Biswas, F Merien, J Lu, DX Liu, M Chen, S Zhou, Y Li Expert opinion on therapeutic targets 21 (5), 511-530, 2017 | 128 | 2017 |
| Identification of MRP2 as a targetable factor limiting oxaliplatin accumulation and response in gastrointestinal cancer K Myint, R Biswas, Y Li, N Jong, S Jamieson, J Liu, C Han, C Squire, ... New Zealand Society for Oncology 50th Anniversary Meeting, Queenstown, New …, 2018 | 28 | 2018 |
| Transport-mediated oxaliplatin resistance associated with endogenous overexpression of MRP2 in Caco-2 and PANC-1 cells R Biswas, P Bugde, J He, F Merien, J Lu, DX Liu, K Myint, J Liu, ... Cancers 11 (9), 1330, 2019 | 20 | 2019 |
| Application of CRISPR-Cas9 System to study biological barriers to drug delivery J He, R Biswas, P Bugde, J Li, DX Liu, Y Li Pharmaceutics 14 (5), 894, 2022 | 4 | 2022 |
| Auckland University of Technology R Biswas New Zealand, 0 | 4 | |
| Aidi injection, a traditional Chinese medicine extract, reverses Gefitinib resistance in non-small cell lung cancer cells R Biswas, C Yang, W Lu, J He, T Chen, F Tian, Y Li European Journal of Integrative Medicine 46, 101368, 2021 | 3 | 2021 |
| Multidrug resistance protein 5 affects cell proliferation, migration and gemcitabine sensitivity in pancreatic cancer MIA Paca‑2 and PANC‑1 cells J He, P Bugde, J Li, R Biswas, S Li, X Yang, F Tian, Z Wu, Y Li Oncology Reports 51 (1), 1-12, 2024 | 2 | 2024 |
| MRP2 as a Targetable Oxaliplatin Resistance Factor in Gastrointestinal Cancer R Biswas Auckland University of Technology, 2018 | | 2018 |
| Silencing ABCC2 transporter gene enhances the oxaliplatin chemo-sensitivity in colorectal cancer cells R Biswas, F Merien, M McKeage, Y Li 2017 Joint APSA-ASCEPT Annual Conference, Brisbane, Queensland (DOI:10.13140 …, 2017 | | 2017 |
| Silencing ABCC2 transporter gene enhances the anticancer activity induced by oxaliplatin in pancreatic cancer R Biswas, F Merien, J Lu, M McKeage, Y Li ASCEPT New Zealand 2017, Queenstown, New Zealand., 2017 | | 2017 |
| Modulation of multidrug resistance protein 2 (MRP2) by RNA interference (RNAi) increases the chemo-sensitivity of HepG2 cells to oxaliplatin R Biswas, F Merien, L Jun, J Paxton, M McKeage, Y Li the Australasia Society of Clinical and Experimental Pharmacologist and …, 2016 | | 2016 |
| Effects of modulation of multidrug resistance associated protein 2 (MRP2) on oxaliplatin efficacy in human gastrointestinal (GI) cancer R Biswas School of Applied Science Showcase, AUT, 2016 | | 2016 |
Yan LiSchool of Science, AUTVerified email at aut.ac.nz
